[18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer-Reference-Cited by-同舟云学术

[18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer

Published:2018-05-23 Issue:5 Volume:13 Page:e0197754
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Raccagni Isabella,Belloli Sara,Valtorta Silvia,Stefano Alessandro,Presotto Luca,Pascali Claudio,Bogni Anna,Tortoreto Monica,Zaffaroni Nadia,Daidone Maria Grazia,Russo Giorgio,Bombardieri Emilio,Moresco Rosa Maria^ORCID

Funder

PIO (Programma Integrato Oncologia) of MIUR

Associazione Italiana per la Ricerca sul Cancro

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. Histological, molecular and functional subtypes of breast cancers;GK Malhotra;Cancer biology & therapy,2010

2. Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?;F Le Du;Oncotarget,2015

3. Triple-negative breast cancer;RD Chacon;Breast cancer research: BCR,2010

4. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer;C Liedtke;Journal of clinical oncology: official journal of the American Society of Clinical Oncology,2008

5. Pathologic complete response after neoadjuvant therapy of breast cancer: pitfalls and shortcomings;G von Minckwitz;Breast cancer research and treatment,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovations in Positron Emission Tomography and State of the Art in the Evaluation of Breast Cancer Treatment Response;Journal of Clinical Medicine;2023-12-27

2. Evaluating [18F]FDG and [18F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models;International Journal of Molecular Sciences;2023-09-15

3. Metabolic Imaging as a Tool to Characterize Chemoresistance and Guide Therapy in Triple-Negative Breast Cancer (TNBC);Molecular Cancer Research;2023-06-21

4. Mathematical Model of Triple-Negative Breast Cancer in Response to Combination Chemotherapies;Bulletin of Mathematical Biology;2022-12-21

5. A New Preclinical Decision Support System Based on PET Radiomics: A Preliminary Study on the Evaluation of an Innovative 64Cu-Labeled Chelator in Mouse Models;Journal of Imaging;2022-03-30